Browse Category

Investment Analysis News 21 December 2025

Ondas Holdings (ONDS) Stock News on Dec. 21, 2025: December Deals, Defense Expansion, and Analyst Forecasts for 2026

Ondas Holdings (ONDS) Stock News on Dec. 21, 2025: December Deals, Defense Expansion, and Analyst Forecasts for 2026

Dec. 21, 2025 — Ondas Holdings Inc. (NASDAQ: ONDS) has become one of the market’s more polarizing small-cap defense-tech stories: part autonomous drones, part counter-drone (“counter-UAS”), part ground robotics, and—often forgotten in the headlines—part private industrial wireless networking. December brought a rapid sequence of acquisitions, contract wins, and SEC filings that collectively reshaped the near-term narrative for Ondas Holdings stock heading into 2026. Ondas Holdings Inc.+2Ondas Holdings Inc.+2 As of the most recent close (Friday, Dec. 19, 2025), ONDS finished around $9.22, up roughly 18% on the day, after an unusually heavy session with roughly 125.8 million shares traded—eye-catching volume
Nike Stock (NKE) Week-Ahead Outlook: Tariffs, China, and Post-Earnings Volatility in Focus (Dec. 22–26, 2025)

Nike Stock (NKE) Week-Ahead Outlook: Tariffs, China, and Post-Earnings Volatility in Focus (Dec. 22–26, 2025)

As of Dec. 21, 2025, Nike, Inc. (NYSE: NKE) enters a holiday-shortened week with investors still digesting a sharp post-earnings selloff—and with a familiar question back at center stage: is the turnaround gaining traction, or simply getting more expensive? Reuters Nike shares closed at $58.71 on Friday (Dec. 19) after dropping roughly 11%, marking a seven-month low and leaving the stock down about 22% year-to-date (per Reuters). Reuters For the coming week (Dec. 22–26), trading conditions will matter as much as headlines. The NYSE will close early at 1:00 p.m. ET on Wednesday, Dec. 24, and will be closed on
Lam Research Stock Week Ahead (LRCX): Analysts Lift Targets as AI Chip Spending Outlook Brightens Into a Holiday-Shortened Market

Lam Research Stock Week Ahead (LRCX): Analysts Lift Targets as AI Chip Spending Outlook Brightens Into a Holiday-Shortened Market

Week ahead: Dec. 22–26, 2025 (report written Dec. 21, 2025) Lam Research Corporation (NASDAQ: LRCX) is heading into the Christmas week on a surge of optimism that has pushed the semiconductor equipment maker to fresh highs—powered by bullish analyst notes, strong AI-driven demand signals from the chip ecosystem, and improving expectations for 2026 capital spending. The catch for traders: next week’s calendar is short and liquidity can be thin, which can magnify both breakouts and pullbacks. Below is a detailed, news-driven look at what’s moving Lam Research stock right now—and what matters most in the coming week. Where Lam Research
Cisco Stock (CSCO) Week-Ahead Outlook: AI Networking Tailwinds Meet a New Zero‑Day Risk (Dec 22–26, 2025)

Cisco Stock (CSCO) Week-Ahead Outlook: AI Networking Tailwinds Meet a New Zero‑Day Risk (Dec 22–26, 2025)

Cisco Systems, Inc. (NASDAQ: CSCO) enters the Christmas-shortened trading week with momentum: shares last traded around $78.42 (latest available close from Friday, Dec. 19, 2025) and sit within reach of a $80.82 52‑week high. Simply Wall St+1 But the coming week isn’t just about “Santa rally” seasonality and thin liquidity. Investors will be balancing (1) a headline cyber risk tied to a critical, actively exploited zero‑day in Cisco’s email security appliances, against (2) a strengthening AI-and-campus-refresh growth narrative that has pushed Wall Street targets higher into year-end. Below is a detailed, week-ahead CSCO stock report as of Sunday, Dec. 21,
Netflix (NFLX) Stock Week Ahead: Warner Bros Deal Headlines, Analyst Targets, and Key Levels to Watch (Dec. 22–26, 2025)

Netflix (NFLX) Stock Week Ahead: Warner Bros Deal Headlines, Analyst Targets, and Key Levels to Watch (Dec. 22–26, 2025)

As the market heads into a holiday-shortened trading week, Netflix, Inc. (NASDAQ: NFLX) is entering a critical stretch where headline risk—not earnings—may be the biggest near-term catalyst. Investors are trying to balance three big forces: (1) deal-driven volatility tied to Netflix’s proposed acquisition of Warner Bros. Discovery assets, (2) a split Wall Street narrative that still leans constructive over 12 months but has turned more cautious in the near term, and (3) a technical setup that looks oversold after a sharp breakdown from recent highs. Netflix shares last traded around $94.39 (split-adjusted), with the latest available prints reflecting Friday’s close
Amicus Therapeutics Stock (FOLD) News: BioMarin’s $14.50 Cash Buyout, Deal Timeline, and the Latest Forecasts (Dec. 21, 2025)

Amicus Therapeutics Stock (FOLD) News: BioMarin’s $14.50 Cash Buyout, Deal Timeline, and the Latest Forecasts (Dec. 21, 2025)

As of Sunday, December 21, 2025, Amicus Therapeutics, Inc. (NASDAQ: FOLD) has effectively shifted from a “biotech story stock” to a deal-driven stock. The reason is simple and decisive: BioMarin Pharmaceutical (NASDAQ: BMRN) agreed to acquire Amicus in an all-cash transaction priced at $14.50 per share, putting a hard cap on the near-term upside—unless a competing bid emerges. SEC+1 With U.S. markets closed for the weekend, the most recent close available is $14.18 (Dec. 19, 2025)—a roughly 30% one-day jump that pushed shares close to the deal price and turned the remaining gap into a classic merger-arbitrage spread. StockAnalysis Below
Oracle Stock (ORCL) Week Ahead: TikTok Joint Venture Headlines, OpenAI “Stargate” Spending Fears, and Key Levels to Watch (Dec. 22–26, 2025)

Oracle Stock (ORCL) Week Ahead: TikTok Joint Venture Headlines, OpenAI “Stargate” Spending Fears, and Key Levels to Watch (Dec. 22–26, 2025)

Published: December 21, 2025 Oracle Corporation (NYSE: ORCL) heads into a holiday-shortened Christmas trading week with two powerful forces pulling the stock in opposite directions: a fresh catalyst from the newly signed TikTok U.S. joint venture agreement, and ongoing investor anxiety over Oracle’s debt-fueled AI data center buildout tied to OpenAI and the broader “Stargate” infrastructure push. The result is a stock that can move sharply on headlines—especially when liquidity thins around the holidays. For traders and longer-term investors alike, the coming week (Dec. 22–26) is less about Oracle-specific scheduled events and more about macro data, year-end positioning, and any
NVIDIA Stock (NVDA) Week Ahead: China H200 Export Review, Intel Investment Clearance, and Blackwell Demand in Focus (Dec. 22–26, 2025)

NVIDIA Stock (NVDA) Week Ahead: China H200 Export Review, Intel Investment Clearance, and Blackwell Demand in Focus (Dec. 22–26, 2025)

NVIDIA Corporation (NASDAQ: NVDA) heads into the Christmas-shortened trading week with a rare mix of policy-driven upside and policy-driven risk. By Sunday, 21.12.2025, the stock’s near-term narrative has become less about “AI demand” in the abstract—and more about who can legally buy which NVIDIA chips, where they can be used, and what Washington might do next. The latest official quote shows NVDA at $180.99, up $6.71 (+3.85%) versus the prior close, with a recent session range of $175.57–$181.37 and volume around 325 million shares. Below is the week-ahead briefing: the most relevant current news, the freshest market-wide catalysts, and the
Space & Satellite Tech Stocks Week Ahead: Rocket Lab’s $816M Space Force Win, AST SpaceMobile’s BlueBird 6 Launch, and EchoStar’s Spectrum Spotlight

Space & Satellite Tech Stocks Week Ahead: Rocket Lab’s $816M Space Force Win, AST SpaceMobile’s BlueBird 6 Launch, and EchoStar’s Spectrum Spotlight

Holiday-shortened trading weeks can be deceptively eventful for space and satellite tech stocks: lower liquidity tends to amplify moves, while “hard” catalysts like contract awards, launch milestones, and regulatory headlines still land on the tape. Heading into the week of Dec. 22–26, 2025, investors are digesting a tightly packed stream of headlines and fresh analyst takes published Dec. 19–21—with Rocket Lab (RKLB), AST SpaceMobile (ASTS), Intuitive Machines (LUNR), EchoStar (SATS), and Planet Labs (PL) among the most-discussed names. Below is what moved the group over Dec. 19–21, 2025, and what to watch next as space and satellite stocks set up
Military Tech Stocks Week Ahead (Dec. 22–26, 2025): Space Force Satellite Awards, Drone Dominance, and Analyst Calls in Focus

Military Tech Stocks Week Ahead (Dec. 22–26, 2025): Space Force Satellite Awards, Drone Dominance, and Analyst Calls in Focus

Military tech stocks are heading into the Christmas-shortened trading week with fresh catalysts from December 19–21 that reinforce a clear narrative: modern defense spending is tilting toward space-based sensing, low-cost drones, and software-heavy systems—while investors debate how much of that shift is already priced into 2025’s big gains. Barron’s+3Air & Space Forces Magazine+3Reuters+3 With U.S. equity markets set to close early on Wednesday, December 24, and remain closed on Thursday, December 25, any headlines on contracts, policy, or analyst calls can have an outsized impact in thinner liquidity—especially for smaller-cap “pure-play” defense tech names. Investopedia+2New York Stock Exchange+2 Below is
Micron Technology (MU) Stock News and Forecasts on Dec. 21, 2025: Record Earnings, HBM “Sold Out,” and Wall Street’s New Price Targets

Micron Technology (MU) Stock News and Forecasts on Dec. 21, 2025: Record Earnings, HBM “Sold Out,” and Wall Street’s New Price Targets

Micron Technology, Inc. (NASDAQ: MU) is heading into the final full week of 2025 with fresh momentum—and not the subtle kind. After a blockbuster fiscal first-quarter report and an even louder outlook for the February quarter, Micron stock closed at $265.92 on the latest available tape, capping a sharp, AI-fueled run that has put memory chips back at the center of the semiconductor narrative. Reuters The immediate catalyst is simple: Micron just printed record results and guided to another step-change higher. The deeper catalyst is more structural—and more controversial. Management and multiple analysts are increasingly framing the current environment as
Recursion Pharmaceuticals RXRX Stock News and Forecasts on December 21 2025

Recursion Pharmaceuticals RXRX Stock News and Forecasts on December 21 2025

Recursion Pharmaceuticals, Inc. stock (NASDAQ: RXRX) heads into the week of December 21, 2025 with investors focused on one thing above all: whether newly released clinical data can turn Recursion’s long-running “AI drug discovery” promise into a credible, repeatable pipeline story that ultimately becomes commercial revenue. The near-term backdrop is noisy. RXRX has been highly volatile for years, and even now the share price sits far below its prior highs, a reality that shapes how every catalyst is interpreted. The Motley Fool Below is a roundup of the key RXRX stock news, fresh filings, analyst forecasts, and the most cited
1 119 120 121 122 123 282

Stock Market Today

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

7 February 2026
Walmart shares rose 3.3% Friday to $131.18, up 10% since Jan. 30, as the Dow closed above 50,000 for the first time. The retailer’s market value crossed $1 trillion this week. Investors await January inflation data on Feb. 13 and Walmart’s quarterly results on Feb. 19 for signs of continued momentum.
Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

7 February 2026
Caterpillar shares surged 7.1% to $726.20 Friday, driving the Dow above 50,000 for the first time. The move erased recent losses and followed insider selling by Group President Bob De Lange earlier in the week. Deere and CNH Industrial also gained as investors rotated into industrial stocks. Markets await next week’s U.S. jobs and inflation data.
Go toTop